New research offers alternative to daily injections for diabetics

New research offers alternative to daily injections for diabetics
A new study from researchers in our Department of Pharmacy & Pharmacology proposes an exciting alternative treatment for people with diabetes.

(Medical Xpress)—The impact of latest research from our Department of Pharmacy & Pharmacology could make frequent insulin injections for sufferers of Type 2 diabetes a thing of the past.

While one of the major challenges facing anyone with the condition is the need for frequent, self-administered, injections, this new research proposes an alternative treatment which could be taken in the form of a pill.

The study 'Unsaturated glycoceramides as molecular carriers for mucosal drug delivery of GLP-1' , published recently in The Journal of Controlled Release: Official Journal of the Controlled Release Society, is a collaborative project between the University of Bath's Department of Pharmacy & Pharmacology and researchers at Harvard Medical School.

It reveals that by chemically combining a form of the naturally occurring hormone 'glucagon-like-peptide-1' (GLP-1) with a specific native lipid (known as GM1), the combined material is now capable of passing through the surface cells of the intestine to enter the body as though it had been injected. This could herald a major breakthrough in diabetes treatment by providing patients with an alternative to frequent injections.

Professor Randy Mrsny from our Department of Pharmacy & Pharmacology said: "We are excited about these findings showing the feasibility of this novel approach. We plan to optimise the construction of these molecules and prepare pills that can be tested in models of intestinal absorption.

Obesity is a risk factor for Type 2 diabetes and GLP-1 injection therapy has been shown to not only help regulate blood sugar but also induce weight loss. Thus, our work may have far reaching implications in treating the global challenge of metabolic disease associated with obesity through this easier administration method.

While the application of this finding will likely take 5-8 years to reach patients, this promising first step is essential to start the path of studies required to start this development process."

Worldwide 347 million people have diabetes, of which Type 2 diabetes accounts for approximately 90 per cent of diagnoses. By 2030, the World Health Organisation projects that diabetes will be the 7th leading cause of death. More than 80 per cent of diabetes deaths occur in low and middle-income countries. Researchers suggest that simple lifestyle changes have been shown to be effective in preventing or delaying the onset of Type 2 .

More information: "Unsaturated glycoceramides as molecular carriers for mucosal drug delivery of GLP-1." Te Welscher YM, Chinnapen DJ, Kaoutzani L, Mrsny RJ, Lencer W. J Control Release. 2013 Dec 23;175C:72-78. DOI: 10.1016/j.jconrel.2013.12.013.

add to favorites email to friend print save as pdf

Related Stories

A healthy side effect of diabetes drug

Sep 23, 2013

(Medical Xpress)—New research has shown the promising potential of a glucose-regulating drug to improve the condition of arteries for diabetes sufferers, possibly protecting them against heart attack or ...

Multihormone reverses metabolic damage of high calorie diet

Jan 15, 2014

Importantly, the scientists found out that treatment of obese mice with this GLP-1/Glucagon co-agonist improves metabolism and body weight associated with restored function of the weight lowering hormone leptin, even in the ...

Amino acid with promising anti-diabetic effects

Sep 09, 2013

New experiments conducted by researchers from the University of Copenhagen show that the amino acid arginine – found in a wide variety of foods such as salmon, eggs and nuts – greatly improves the body's ...

Recommended for you

Screening for diabetes at dental visits using oral blood

Feb 26, 2015

It is estimated that 8.1 million of the 29.1 million Americans living with diabetes are undiagnosed and many who have diabetes have poor glycemic control. Given that each year many Americans visit a dental provider but not ...

CBT, sertraline insufficient in diabetes and depression

Feb 26, 2015

(HealthDay)—For patients with diabetes and depression, improvements in depression are seen with cognitive behavioral therapy (CBT) or sertraline, with a significant advantage for sertraline, but glycemic ...

Early signs in young children predict type 1 diabetes

Feb 26, 2015

New research shows that it is possible to predict the development of type 1 diabetes. By measuring the presence of autoantibodies in the blood, it is possible to detect whether the immune system has begun to break down the ...

Daily menu plan reduces blood sugar significantly

Feb 25, 2015

A large group of people with diabetes who followed a menu plan created by University of Alberta nutrition researchers for just three months significantly reduced their blood sugar levels.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.